Anticipated Out‐Of‐Pocket Costs and Prostate Cancer Management Among Men With Commercial Insurance
Among commercially insured men with prostate cancer, predicted out-of-pocket costs varied substantially. However, the choice of management, immediate treatment or conservative management, appears insensitive (i.e., inelastic) to patient anticipated financial liability.
Authors
- Brent K. Hollenbeck
- Dawson Hill (ORCID: https://orcid.org/0000-0002-8560-5345)
- Christopher Dall (ORCID: https://orcid.org/0000-0002-2207-0531)
- Addison Shay (ORCID: https://orcid.org/0000-0003-1651-317X)
- Paula Guro (ORCID: https://orcid.org/0009-0002-0103-5734)
- Avinash Maganty (ORCID: https://orcid.org/0000-0001-6436-6667)
- Sarah Leick
- Vahakn B. Shahinian (ORCID: https://orcid.org/0000-0003-3280-7821)
- Mary Oerline (ORCID: https://orcid.org/0000-0002-0264-6951)
- Arnav Srivastava (ORCID: https://orcid.org/0000-0002-9772-1415)
- Preeti Chachlani
- Xiu Liu (ORCID: https://orcid.org/0000-0001-7818-8312)
- Samuel R. Kaufman
Institutions
- University of Michigan (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1002/cam4.71184
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute